Cited by 155Drug-Induced Adverse ReactionsDrug-Induced Hepatotoxicity and ProtectionGlutathione Transferases and Polymorphisms

The DOI matches its Crossref record.

Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity

Cribb, A E, Miller, M, Leeder, J S, Hill, J, Spielberg, S P·1991·Drug Metabolism and Disposition

DOI 10.1016/s0090-9556(25)08967-6

Open this paper in CoChat — free account

Abstract

N4-oxidation of sulfonamides has been implicated in the pathogenesis of idiosyncratic reactions to these antimicrobials. In vitro toxicity assays employing mononuclear leukocytes as target cells have shown that the toxicity of sulfamethoxazole hydroxylamine (SMX-HA) is inhibited by exogenous glutathione, suggesting that conjugation with glutathione is an important detoxification pathway. However, in these experiments, significant depletion of cellular glutathione only occurred at concentrations of SMX-HA greater than or equal to 300 microM. At concentrations of SMX-HA which produce 50% toxicity in mononuclear leukocytes (approximately 100 microM), there was not a significant loss of glutathione. SMX-HA also caused a small but significant increase in oxidized glutathione concentrations. In cell-free experiments, reduced glutathione (GSH) prevented the autooxidation of SMX-HA to nitrososulfamethoxazole (nitroso-SMX). During this process, oxidized glutathione was formed. GSH rapidly reacted with nitroso-SMX to form a labile semimercaptal conjugate. Physiologically relevant concentrations of GSH (i.e. 1 mM) favored thiolytic cleavage of the semimercaptal to form SMX-HA. Isomerization of the semimercaptal to the more stable sulfinamide occurred at low GSH concentrations. Purified glutathione transferases had no effect on the reaction of SMX-HA with GSH. Therefore, glutathione is important in protecting cells from the toxicity of SMX-HA largely by preventing its further oxidation to nitroso-SMX. Stable glutathione conjugates are likely to be formed only in small quantities under physiological conditions. Conjugation with glutathione would not be expected to be a major pathway for clearance of the hydroxylamine and nitroso metabolites of sulfonamides.

Integrity signals

Registry

Crossref · 10.1016/s0090-9556(25)08967-6

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Still being checked.

Sorted by citations

Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States
Stepan, A. F., Walker, D. P., Bauman, J. N., Price, D. A., Baillie, T. A., Kalgutkar, A. S. S., & Aleo, M. D. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200168d · Cited by 725
Cutaneous Drug Reactions
Svensson, C. K., Cowen, E. W., & Gaspari, A. A. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01501-1 · Cited by 274
Immune pathomechanism of drug hypersensitivity reactions
Pichler, W. J., Naisbitt, D. J., & Park, B. K. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.048 · Cited by 186
Deleterious Effects of Reactive Metabolites
Attia, S. M. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.4.13246 · Cited by 177
The danger hypothesis—potential role in idiosyncratic drug reactions
Pirmohamed, M., Naisbitt, D. J., Gordon, F., & Park, B. K. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00255-x · Cited by 169
Mechanisms of NSAID-Induced Hepatotoxicity
Boelsterli, U. A. (2002) · Drug Safety · doi:10.2165/00002018-200225090-00003 · Cited by 164
A Role for Bioactivation and Covalent Binding within Epidermal Keratinocytes in Sulfonamide-Induced Cutaneous Drug Reactions
Reilly, T. P., Lash, L. H., Doll, M. A., Hein, D. W., Woster, P. M., & Svensson, C. K. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00985.x · Cited by 150
Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation
Naisbitt, D. J., Farrell, J., Gordon, S. F., Maggs, J. L., Burkhart, C., Pichler, W. J., Pirmohamed, M., & Park, B. K. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.628 · Cited by 141
Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity
Naisbitt, D. J., Hough, S. J., Gill, H., Pirmohamed, M., Kitteringham, N. R., & Park, B. K. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702453 · Cited by 134
Idiosyncratic toxicity associated with potentiated sulfonamides in the dog
Trepanier, L. A. (2004) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2004.00576.x · Cited by 138
Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism‐dependent haptenation and T‐cell proliferation in vivo
Naisbitt, D. J., Gordon, S. F., Pirmohamed, M., Burkhart, C., Cribb, A. E., Pichler, W. J., & Park, B. K. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704074 · Cited by 133
Self-citation
The Biochemistry of Drug Metabolism – An Introduction
Testa, B., & Krämer, S. D. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890199 · Cited by 137
Advances in molecular toxicology–towards understanding idiosyncratic drug toxicity
Park, B. K., Kitteringham, N. R., Powell, H., & Pirmohamed, M. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00303-6 · Cited by 129
Sulfamethoxazole and Its Metabolite Nitroso Sulfamethoxazole Stimulate Dendritic Cell Costimulatory Signaling
Sanderson, J. P., Naisbitt, D. J., Farrell, J., Ashby, C. A., TUCKER, M., Rieder, M. J., Pirmohamed, M., Clarke, S. E., & Park, B. K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5533 · Cited by 127
Metabolic activation in drug allergies
Park, B. K., Naisbitt, D. J., Gordon, S. F., Kitteringham, N. R., & Pirmohamed, M. (2001) · Toxicology · doi:10.1016/s0300-483x(00)00397-8 · Cited by 122
Should Celecoxib Be Contraindicated in Patients Who Are Allergic to Sulfonamides?
Knowles, S. R., Shapiro, L. E., & Shear, N. H. (2001) · Drug Safety · doi:10.2165/00002018-200124040-00001 · Cited by 117
In vitroanalysis of metabolic predisposition to drug hypersensitivity reactions
Riley, R. J., & Leeder, J. S. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03463.x · Cited by 114
Structural Alerts, Reactive Metabolites, and Protein Covalent Binding: How Reliable Are These Attributes as Predictors of Drug Toxicity?
Kalgutkar, A. S. S., & Didiuk, M. T. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900055 · Cited by 104
Allergic adverse reactions to sulfonamides
Choquet‐Kastylevsky, G., Vial, T., & Descotes, J. (2002) · Current Allergy and Asthma Reports · doi:10.1007/s11882-002-0033-y · Cited by 102
Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity
Park, B. K., Laverty, H., Srivastava, A., Antoine, D. J., Naisbitt, D. J., & Williams, D. P. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.09.011 · Cited by 104
Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions
Kongpan, T., Mahasirimongkol, S., Konyoung, P., Kanjanawart, S., Chumworathayi, P., Wichukchinda, N., Kidkeukarun, R., Preechakul, S., Khunarkornsiri, U., Bamrungram, W., et al. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000153 · Cited by 93
Influence of reduced glutathione on the proliferative response of sulfamethoxazole‐specific and sulfamethoxazole‐metabolite‐specific human CD4+ T‐cells
Burkhart, C., von Greyerz, S., Depta, J. P. H., Naisbitt, D. J., Britschgi, M., Park, K. B., & Pichler, W. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703845 · Cited by 95
Comparison of the In Vitro Cytotoxicity of Hydroxylamine Metabolites of Sulfamethoxazole and Dapsone
Reilly, T. P., Bellevue, F. H., Woster, P. M., & Svensson, C. K. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00547-9 · Cited by 90
Drug-induced bile duct injury
Visentin, M., Lenggenhager, D. M., Gai, Z., & Kullak-Ublick, G. A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.033 · Cited by 89
The Generation, Detection, and Effects of Reactive Drug Metabolites
Stachulski, A. V., Baillie, T. A., Park, B. K., Obach, R. S., Dalvie, D., Williams, D. P., Srivastava, A., Regan, S., Antoine, D. J., Goldring, C. E., et al. (2012) · Medicinal Research Reviews · doi:10.1002/med.21273 · Cited by 89
Sulfonamide Hypersensitivity: Fact and Fiction
Khan, D. A., Knowles, S. R., & Shear, N. H. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.05.034 · Cited by 87
The Role of Active Metabolites in Drug Toxicity
Pirmohamed, M., Kitteringham, N. R., & Park, B. K. (1994) · Drug Safety · doi:10.2165/00002018-199411020-00006 · Cited by 86
Multiple Adduction Reactions of Nitroso Sulfamethoxazole with Cysteinyl Residues of Peptides and Proteins: Implications for Hapten Formation
Callan, H. E., Jenkins, R. E., Maggs, J. L., Lavergne, S. N., Clarke, S. E., Naisbitt, D. J., & Park, B. K. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900034r · Cited by 84
N-acetyltransferases: Pharmacogenetics and clinical consequences of polymorphic drug metabolism
Spielberg, S. P. (1996) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02353477 · Cited by 81
Metabolism of sulfamethoxazole in Arabidopsis thaliana cells and cucumber seedlings
Dudley, S., Sun, C., Jiang, J., & Gan, J. J. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.07.094 · Cited by 76
Chemical toxicology: reactive intermediates and their role in pharmacology and toxicology
Erve, J. C. L. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.923 · Cited by 75
Characterization of Sulfamethoxazole and Sulfamethoxazole Metabolite-Specific T-Cell Responses in Animals and Humans
Farrell, J., Naisbitt, D. J., Drummond, N. S., Depta, J. P. H., Vilar, F. J., Pirmohamed, M., & Park, B. K. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.050112 · Cited by 74
Mechanism of bioactivation and covalent binding of 2,4,6-trinitrotoluene
Leung, K., Yao, M., Stearns, R. A., & Chiu, S. L. (1995) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)03606-9 · Cited by 73
Drug metabolism, danger signals, and drug-induced hypersensitivity
Gruchalla, R. S. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118509 · Cited by 74
Reactive metabolites and their role in drug reactions
Naisbitt, D. J., Williams, D. P., Pirmohamed, M., Kitteringham, N. R., & Park, B. K. (2001) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200108000-00007 · Cited by 70
Haptenation of Sulfonamide Reactive Metabolites to Cellular Proteins
Manchanda, T., Hess, D. A., Dale, L., Ferguson, S. S. G., & Rieder, M. J. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1011 · Cited by 69
The Relationship Between the Disposition and Immunogenicity of Sulfamethoxazole in the Rat
Gill, H., Hough, S. J., Naisbitt, D. J., Maggs, J. L., Kitteringham, N. R., Pirmohamed, M., & Park, B. K. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36867-3 · Cited by 69
Synthesis and reactions of nitroso sulphamethoxazole with biological nucleophiles: Implications for immune mediated toxicity
Naisbitt, D. J., O’Neill, P. M., Pirmohamed, M., & Park, B. K. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(96)00260-0 · Cited by 67
Pharmacogenetics of Adverse Drug Reactions
Osanlou, O., Pirmohamed, M., & Daly, A. K. (2018) · Advances in pharmacology · doi:10.1016/bs.apha.2018.03.002 · Cited by 69
Drug Antigenicity, Immunogenicity, and Costimulatory Signaling: Evidence for Formation of a Functional Antigen through Immune Cell Metabolism
Elsheikh, A., Lavergne, S. N., Castrejón-Flores, J. L., Farrell, J., Wang, H., Sathish, J. G., Pichler, W. J., Park, B. K., & Naisbitt, D. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000889 · Cited by 66
Role of bioactivation in drug-induced hypersensitivity reactions
Sanderson, J. P., Naisbitt, D. J., & Park, B. K. (2006) · The AAPS Journal · doi:10.1208/aapsj080107 · Cited by 61
Toxicophores: groups and metabolic routes associated with increased safety risk.
Williams, D. P., & Naisbitt, D. J. (2002) · PubMed · Cited by 61
Slow acetylator phenotype and genotype in HIV‐positive patients with sulphamethoxazole hypersensitivity
Alfirevic, A., Stalford, A. C., Vilar, F. J., Wilkins, E., Park, B. K., & Pirmohamed, M. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01754.x · Cited by 62
Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes
Vyas, P. M., Roychowdhury, S., Woster, P. M., & Svensson, C. K. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.023 · Cited by 61
Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions
Kalish, R. S., LaPorte, A., Wood, J. A., & Johnson, K. L. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90202-x · Cited by 60
The importance of hapten–protein complex formation in the development of drug allergy
Faulkner, L., Meng, X., Park, B. K., & Naisbitt, D. J. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000078 · Cited by 57
Methemoglobin Formation by Hydroxylamine Metabolites of Sulfamethoxazole and Dapsone: Implications for Differences in Adverse Drug Reactions
Reilly, T., Woster, P. M., & Svensson, C. K. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38046-2 · Cited by 57
Immediate‐type hypersensitivity drug reactions
Stone, S. F., Phillips, E. J., Wiese, M. D., Heddle, R. J., & Brown, S. G. A. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12297 · Cited by 53
Characterization of the Formation and Localization of Sulfamethoxazole and Dapsone-Associated Drug-Protein Adducts in Human Epidermal Keratinocytes
Roychowdhury, S., Vyas, P. M., Reilly, T. P., Gaspari, A. A., & Svensson, C. K. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086009 · Cited by 56
“Danger” Conditions Increase Sulfamethoxazole-Protein Adduct Formation in Human Antigen-Presenting Cells
Lavergne, S. N., Wang, H., Callan, H., Park, B. K., & Naisbitt, D. J. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155374 · Cited by 55
Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole.
van der Ven, A., Mantel, M., Vree, T. B., Koopmans, P., & van der Meer, J. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04339.x · Cited by 52
Reactions of oxidatively activated arylamines with thiols: reaction mechanisms and biologic implications. An overview.
Eyer, P. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102s6123 · Cited by 51
Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis
Elsheikh, A., Castrejón-Flores, J. L., Lavergne, S. N., Whitaker, P., Monshi, M. M., Callan, H., El-Ghaiesh, S. H., Farrell, J., Pichler, W. J., Peckham, D. G., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.1119 · Cited by 48
Specific polyclonal-based immunoassays for sulfathiazole
Pastor-Navarro, N., Garc�a-Bover, C., Maquieira, �., & Puchades, R. (2004) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-004-2683-1 · Cited by 47
Patients with Delayed-Onset Sulfonamide Hypersensitivity Reactions Have Antibodies Recognizing Endoplasmic Reticulum Luminal Proteins
Cribb, A. E., Pohl, L. R., Spielberg, S. P., & Leeder, J. S. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36874-0 · Cited by 46
Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole
van der Ven, A., Vree, T., van Ewijk‐Beneken Kolmer, E., Koopmans, P., & van der Meer, J. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05721.x · Cited by 45
Safety of Celecoxib in Individuals Allergic to Sulfonamide
Shapiro, L. E., Knowles, S. R., Weber, E., Neuman, M. G., & Shear, N. H. (2003) · Drug Safety · doi:10.2165/00002018-200326030-00004 · Cited by 45
Mechanisms of drug reactions: The metabolic track
Shapiro, L. E., & Shear, N. H. (1996) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/s1085-5629(96)80034-4 · Cited by 45
Idiosyncratic Drug Hepatotoxicity Revisited: New Insights from Mechanistic Toxicology
Boelsterli, U. A. (2003) · Toxicology Mechanisms and Methods · doi:10.1080/15376510309824 · Cited by 44
Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients
Wang, D., Curtis, A., Papp, A. C., Koletar, S. L., & Para, M. F. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-32 · Cited by 46
Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells
Summan, M., & Cribb, A. E. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00060-1 · Cited by 43
Time-course of toxicity of reactive sulfonamide metabolites
Rieder, M. J., Krause, R. S., & Bird, I. A. (1995) · Toxicology · doi:10.1016/0300-483x(94)02900-f · Cited by 42
Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDS
Wolkenstein, P., Loriot, M., Aractingi, S., Cabelguenne, A., Beaune, P. H., & Chosidow, O. (2000) · Pharmacogenetics · doi:10.1097/00008571-200012000-00007 · Cited by 41
Monitoring Adverse Drug Reactions to Sulfonamide Antibiotics in Human Immunodeficiency Virus–Infected Individuals
Neuman, M. G., Malkiewicz, I. M., Phillips, E. J., Rachlis, A., Ong, D., Yeung, E., & Shear, N. H. (2002) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200212000-00008 · Cited by 40
Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers*
Mitra, A., Thummel, K. E., Kalhorn, T. F., Kharasch, E. D., Unadkat, J. D., & Slattery, J. T. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)80011-7 · Cited by 40
Sulfonamide Drug Allergy
Dorn, J. M., Alpern, M. L., McNulty, C. M. G., & Volcheck, G. W. (2018) · Current Allergy and Asthma Reports · doi:10.1007/s11882-018-0791-9 · Cited by 36
Combination of GSH Trapping and Time-Dependent Inhibition Assays as a Predictive Method of Drugs Generating Highly Reactive Metabolites
Nakayama, S., Takakusa, H., Watanabe, A., Miyaji, Y., Suzuki, W., Sugiyama, D., Shiosakai, K., Honda, K., Okudaira, N., Izumi, T., et al. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.039180 · Cited by 36
Covalent Binding of the Nitroso Metabolite of Sulfamethoxazole Is Important in Induction of Drug-Specific T-Cell Responses in Vivo
Cheng, L., Stewart, B. J., You, Q., Petersen, D. R., Ware, J. A., Piccotti, J. R., Kawabata, T. T., & Ju, C. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043273 · Cited by 34
Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus
Soejima, M., Sugiura, T., Kawaguchi, Y., Kawamoto, M., Katsumata, Y., Takagi, K., Nakajima, A., Mitamura, T., Mimori, A., Hara, M., et al. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2134 · Cited by 34
Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso
Lavergne, S. N., Kurian, J. R., Bajad, S. U., Maki, J. E., Yoder, A. R., Guzinski, M. V., Graziano, F. M., & Trepanier, L. A. (2006) · Toxicology · doi:10.1016/j.tox.2006.01.018 · Cited by 33
Toxicophores, reactive metabolites and drug safety: when is it a cause for concern?
Kalgutkar, A. S. S., Fate, G. D., Didiuk, M. T., & Bauman, J. N. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.4.515 · Cited by 32
Recognition of Local Anesthetics by αβ+ T Cells
Zanni, M. P., von Greyerz, S., Hari, Y., Schnyder, B., & Pichler, W. J. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00484.x · Cited by 32
Reduction of Sulfamethoxazole Hydroxylamine (SMX-HA) by the Mitochondrial Amidoxime Reducing Component (mARC)
Ott, G., Plitzko, B., Krischkowski, C., Reichmann, D., Bittner, F., Mendel, R. R., Kunze, T., Clement, B., & Havemeyer, A. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500174u · Cited by 30
Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides
Elzagallaai, A. A., Sultan, E. A., Bend, J. R., Abuzgaia, A. M., Loubani, E., & Rieder, M. J. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1535 · Cited by 33
Plasma Ascorbate Deficiency Is Associated With Impaired Reduction of Sulfamethoxazole-Nitroso in HIV Infection
Trepanier, L. A., Yoder, A. R., Bajad, S. U., Beckwith, M. D., Bellehumeur, J. L., & Graziano, F. M. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200408150-00007 · Cited by 30
Increased Adverse Drug Reactions to Antimicrobials and Anticonvulsants in Patients with HIV Infection
Lin, D., TUCKER, M., & Rieder, M. J. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g525 · Cited by 31
Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides
Neuman, M. G., Shear, N. H., Malkiewicz, I. M., Taeri, M., Shapiro, L. E., Krivoy, N., Haber, J. A., Gómez, M., Fish, J. S., Cartotto, R. C., et al. (2007) · Translational research · doi:10.1016/j.trsl.2006.12.001 · Cited by 32
Metabolic and Chemical Origins of Cross-Reactive Immunological Reactions to Arylamine Benzenesulfonamides: T-Cell Responses to Hydroxylamine and Nitroso Derivatives
Castrejón-Flores, J. L., Lavergne, S. N., El-Sheikh, A., Farrell, J., Maggs, J. L., Sabbani, S., O’Neill, P. M., Park, B. K., & Naisbitt, D. J. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900329b · Cited by 34
Characterization of Peroxidases Expressed in Human Antigen Presenting Cells and Analysis of the Covalent Binding of Nitroso Sulfamethoxazole to Myeloperoxidase
Ogese, M. O., Jenkins, R. E., Maggs, J. L., Meng, X., Whitaker, P., Peckham, D. G., Faulkner, L., Park, B. K., & Naisbitt, D. J. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500458k · Cited by 29
Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity
Sacco, J., Abouraya, M., Motsinger‐Reif, A. A., Yale, S. H., McCarty, C. A., & Trepanier, L. A. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328357a735 · Cited by 29
Toxicogenetics in drug development
Park, B. K., & Pirmohamed, M. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00280-6 · Cited by 27
Handling reactive metabolite positives in drug discovery: What has retrospective structure–toxicity analyses taught us?
Kalgutkar, A. S. S. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.09.003 · Cited by 26
Dapsone induces oxidative stress and impairs antioxidant defenses in rat liver
Veggi, L. M., Pretto, L., Ochoa, E. J., Catania, V. A., Luquita, M. G., Taborda, D. R., Pozzi, E. J. S., Ikushiro, S., Coleman, M. D., Roma, M. G., et al. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.05.016 · Cited by 25
N-acetyltransferase: the practical consequences of polymorphic activity in man
Mitchell, S. C. (2019) · Xenobiotica · doi:10.1080/00498254.2019.1618511 · Cited by 24
Influence ofNAT2Polymorphisms on Sulfamethoxazole Pharmacokinetics in Renal Transplant Recipients
Kagaya, H., Miura, M., Niioka, T., Saito, M., Numakura, K., Habuchi, T., & Satoh, S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05037-11 · Cited by 23
Aerobic 2- and 4-nitroreduction of CB 1954 by human liver
Tang, M. H. Y., Helsby, N. A., Wilson, W. R., & Tingle, M. D. (2005) · Toxicology · doi:10.1016/j.tox.2005.07.021 · Cited by 23
Direct ELlSAs for Sulfathiazole in Milk and Honey with Special Emphasis on Enzyme Conjugate Preparation
Thomson, C. A., & Sporns, P. (1995) · Journal of Food Science · doi:10.1111/j.1365-2621.1995.tb05683.x · Cited by 22
Novel Clinical Biomarkers for Drug-Induced Liver Injury
Chen, Y., Guan, S., Guan, Y., Tang, S., Zhou, Y., Wang, X., Bi, H., & Huang, M. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000732 · Cited by 21
Adverse Drug Reactions: Mechanisms and Assessment
Ring, J., & Brockow, K. (2002) · European Surgical Research · doi:10.1159/000048905 · Cited by 23
Immunological principles of T-cell-mediated adverse drug reactions in skin
Naisbitt, D. J., Pirmohamed, M., & Park, B. K. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.2.109 · Cited by 19
Induction of delayed-type hypersensitivity to sulfamethoxazole in mice: role of metabolites
Choquet‐Kastylevsky, G., Santolaria, N., Tédone, R., Aujoulat, M., & Descotes, J. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(00)00313-1 · Cited by 19
Pharmacokinetics of sulfamethoxazole with its hydroxy metabolites and N4-acetyl-, N1-glucuronide conjugates in healthy human volunteers
Vree, T. B., van der Ven, A. J. A. M., Koopmans, P. P., van Ewijk-Beneken Kolmer, E. W. J., & Verwey-van Wissen, C. P. W. G. M. (1995) · Clinical Drug Investigation · doi:10.2165/00044011-199509010-00008 · Cited by 18
Metabolic Disposition and Elimination of Tritum-Labeled Sulfamethoxazole in Pigs, Chickens and Rats
Guo, J., Sun, Y., Zhao, Y., Huang, L., Peng, D., Hao, H., Tao, Y., Chen, D., Cheng, G., Wang, X., et al. (2022) · Metabolites · doi:10.3390/metabo13010057 · Cited by 18
Diagnosis of allergic reactions to sulfonamides
Gruchalla, R. S. (1999) · Allergy · doi:10.1111/j.1398-9995.1999.tb04745.x · Cited by 18
Are drug metabolites able to cause T-cell-mediated hypersensitivity reactions?
Sullivan, A. K., Gibson, A., Park, B. K., & Naisbitt, D. J. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.992780 · Cited by 19
IgE and Drug Allergy: Antibody Recognition of ‘Small’ Molecules of Widely Varying Structures and Activities
Baldo, B. A. (2014) · Antibodies · doi:10.3390/antib3010056 · Cited by 16
Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4 T-cells
HOPKINS, J., Naisbitt, D. J., HUMPHREYS, N., Dearman, R. J., Kimber, I., & PARK, B. (2004) · Toxicology · doi:10.1016/j.tox.2004.08.010 · Cited by 16
Immunochemical Approaches to the Detection of Sulfathiazole in Animal Tissues
Lee, N. A., Holtzapple, C. K., Muldoon, M. T., Deshpande, S. S., & Stanker, L. H. (2001) · Food and Agricultural Immunology · doi:10.1080/09540100051074149 · Cited by 15
Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions
Nakkam, N., Saksit, N., Konyoung, P., Amornpinyo, W., Khunarkornsiri, U., Purimart, D., Pattanacheewapull, O., Naewla, T., Wattanachai, P., Khaeso, K., et al. (2022) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2022.100480 · Cited by 14
Inhibition of cytokine production and interference in IL‐2 receptor‐mediated Jak‐Stat signaling by the hydroxylamine metabolite of sulfamethoxazole
Hess, D. A., O'Leary, E. F., Lee, J. T., Almawi, W. Y., Madrenas, J., & Rieder, M. J. (2001) · The FASEB Journal · doi:10.1096/fj.00-0583fje · Cited by 14

Authors: Cribb, A. E., Miller, M., Leeder, J. S., Hill, J., & Spielberg, S. P.
Affiliations: University of Toronto (CA)
ORCID: Cribb, A E
Leeder, J S
Venue: Drug Metabolism and Disposition
Publisher: Elsevier BV
Published: 1991-09
Volume: 19
Issue: 5
Pages: 900-906
ISSN: 0090-9556 (ISSN-L)
DOI: 10.1016/s0090-9556(25)08967-6
OpenAlex: W1790339004
Cited by: 155
References: 0
Citations by year: 2026: 2 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 7 · 2017: 5 · 2016: 1 · 2015: 2 · 2014: 7 · 2013: 5 · 2012: 7
FWCI: 2.94
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Drug Metabolism and Disposition (publishedVersion)
PubMed (publishedVersion)
PubMed
Topics: Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
Keywords: sulfamethoxazole, reduced glutathione, glutathione conjugation, idiosyncratic drug toxicity, mononuclear leukocytes, glutathione depletion, glutathione disulfide, glutathione S-transferase, drug detoxification
MeSH terms: Cell-Free System, Glutathione, Glutathione Reductase, Humans, Leukocytes, Mononuclear, Inactivation, Metabolic, Oxidation-Reduction, Sulfamethoxazole, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks